Edesa Biotech Overview
- Founded
-
2015

- Status
-
Public
- Employees
-
16

- Stock Symbol
-
EDSA

- Investments
-
1
- Share Price
-
$0.91
- (As of Friday Closing)
Edesa Biotech General Information
Description
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Contact Information
- 100 Spy Court
- Markham, Ontario L3R 5H6
- Canada
Edesa Biotech Timeline
Edesa Biotech Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.91 | $0.90 | $0.76 - $2.81 | $18.7M | 20.6M | 79.7K | -$0.62 |
Edesa Biotech Financials Summary
In Thousands, USD |
TTM 31-Mar-2023 | FY 2022 30-Sep-2022 | FY 2021 30-Sep-2021 | FY 2020 30-Sep-2020 |
---|---|---|---|---|
EV | 10,172 | 1,477 | 89,895 | 74,538 |
Revenue | 0 | 0 | 0 | 329 |
EBITDA | (13,345) | (17,493) | (13,235) | (6,344) |
Net Income | (13,270) | (17,549) | (13,343) | (6,364) |
Total Assets | 10,673 | 11,576 | 14,585 | 10,762 |
Total Debt | 130 | 19 | 99 | 164 |
Edesa Biotech Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Edesa Biotech Comparisons
Industry
Financing
Details
Edesa Biotech Competitors (7)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Citius Pharma | Formerly Angel backed | Cranford, NJ | 00 | 000.00 | 000000000 | 000.00 |
000 00000 | Corporation | Indianapolis, IN | 00000 | 000000 - 000 | ||
00000 000000 00000 | Corporate Backed or Acquired | Boulder, CO | 00 | 000.00 | 00000000 | 000.00 |
00000 | Corporation | Mumbai, India | 00000 | 00000000 | ||
000000 000000 0000 | Formerly VC-backed | Gothenburg, Sweden | 00 | 000.00 | 000000000 | 000.00 |
Edesa Biotech Executive Team (5)
Edesa Biotech Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Carlo Sistilli | Edesa Biotech | Board Member | 000 0000 |
Frank Oakes | Self | Board Member | 000 0000 |
Jennifer Chao | Self | Board Member | 000 0000 |
Lorin Johnson Ph.D | Self | Board Member | 000 0000 |
Par Nijhawan MD | Edesa Biotech | Founder, Chief Executive Officer, Secretary & Board Director | 000 0000 |
Edesa Biotech Signals
Edesa Biotech Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Edesa Biotech Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 00000 | 07-Jun-2019 | 0000000000 | 00.000 | Biotechnology | 000 00000 |